BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
about
The function, regulation and therapeutic implications of the tumor suppressor protein, PMLCurrent and emerging biomarkers of cell death in human disease.ERK5 and Cell Proliferation: Nuclear Localization Is What MattersPromyelocytic leukemia (PML) protein plays important roles in regulating cell adhesion, morphology, proliferation and migrationLC-MS-MS quantitative analysis reveals the association between FTO and DNA methylationPML-mediated signaling and its role in cancer stem cells.Nesprin-2-dependent ERK1/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageingInhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L.Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis.New Strategies to Direct Therapeutic Targeting of PML to Treat CancersAbsence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice.Essential Roles of E3 Ubiquitin Ligases in p53 Regulation.Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in MelanomaPML tumour suppression and beyond: therapeutic implications.Oncogenic signaling of MEK5-ERK5.MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.PML: Not all about Tumor Suppression.
P2860
0a700635b578185bed6b87d81dfc8109da40263411a2a653fe5593fbe27eb6a88eec39d476aa33783c625fa9b9fc2af0195d99b16ed44347db3541d05358ae24dcf18b9f4d47d352654d1ca1a7464de05d36ea9e1b42f56f8f995f5e357d3590040a625d6ee4bd1f20ec1b8c00039fbfb6f1ddf3c37957d46f1172bbae95392be767edeebb99f82ccddb385ddf90cdce6e9c09d16b293cb844e3ac61bc8a0daaef46dee667610395ade575e5d1e7b1e7254dd1e0
P248
Q26779358-CCE1F999-988E-47DE-997F-75B0D70B5FBCQ27690667-EE44C2D2-C939-42CF-8C3C-A266BF531640Q28078572-E46205F8-9366-4501-8C60-F2F23476C02BQ28588291-CB9FA526-02A6-4292-91E8-E4F7160CAD53Q33614862-036CCE49-E2E9-4A70-847E-23A186051DD4Q34337626-85757EE3-C4FD-4F42-A1AE-2CC760A56135Q35941485-87929CE4-5C28-43DA-8B92-3ED6ED24D964Q36545136-26825327-A3FE-43B3-8A0E-0CDFC8CD07E3Q36781128-EF798F98-2A66-490D-8438-E46BEF529702Q36850742-FC8FF830-259B-4806-8E61-5BF8E6B0D622Q37688789-85380FA4-2F78-42A7-95AE-A32CF8C2FDC3Q37691041-BA338C64-1ED2-45D0-AEFF-ED10DE2DCEA9Q37741262-4CBF12BE-2C7D-404B-B44F-4D0C6D404051Q38189168-5A0D8574-6A0C-4477-869B-8EBA92FB2617Q39116456-B11D9097-ED8B-4C51-8E65-80C4881FCE04Q41610131-07AD38D2-F301-4E13-AA10-388646556904Q42107169-B6050CBC-AF21-4C70-8B05-2512FE27F132
P2860
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@ast
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@en
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@en-gb
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@nl
type
label
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@ast
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@en
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@en-gb
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@nl
prefLabel
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@ast
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@en
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@en-gb
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/ONC.2012.332
P407
P50
P577
2012-08-06T00:00:00Z
P5875
P6179
1027855580